Dr Edna C Holmes, DPM - Medicare Podiatrist in Woodbridge, VA

Dr Edna C Holmes, DPM is a medicare enrolled "Podiatrist" provider in Woodbridge, Virginia. Her current practice location is 1700 Rosedale Ct, Woodbridge, Virginia. You can reach out to her office (for appointments etc.) via phone at (703) 494-3070.

Dr Edna C Holmes is licensed to practice in Virginia (license number 0103000695) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1003908898.

Contact Information

Dr Edna C Holmes, DPM
1700 Rosedale Ct,
Woodbridge, VA 22191-3016
(703) 494-3070
(703) 491-9501



Healthcare Provider's Profile

Full NameDr Edna C Holmes
GenderFemale
SpecialityPodiatrist
Location1700 Rosedale Ct, Woodbridge, Virginia
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1003908898
  • Provider Enumeration Date: 09/29/2006
  • Last Update Date: 11/20/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 1254467806
  • Enrollment ID: I20100427000408

Medical Identifiers

Medical identifiers for Dr Edna C Holmes such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003908898NPI-NPPES
9302409MedicaidVA
5407OtherDCPODIATRY
026083OtherVAPODIATRY
00Y336HO1OtherVAINDIVIUAL PTAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
213ES0000XPodiatrist - Sports Medicine 0103000695 (Virginia)Secondary
213ES0000XPodiatrist - Sports Medicine P0474 (District Of Columbia)Secondary
213ES0131XPodiatrist - Foot Surgery 0103000695 (Virginia)Secondary
213ES0131XPodiatrist - Foot Surgery P0474 (District Of Columbia)Secondary
213E00000XPodiatrist 0103000695 (Virginia)Primary
213E00000XPodiatrist P0474 (District Of Columbia)Secondary
213EP0504XPodiatrist - Public Medicine 0103000695 (Virginia)Secondary
213EP0504XPodiatrist - Public Medicine P0474 (District Of Columbia)Secondary
213EP1101XPodiatrist - Primary Podiatric Medicine 0103000695 (Virginia)Secondary
213EP1101XPodiatrist - Primary Podiatric Medicine P0474 (District Of Columbia)Secondary
213ER0200XPodiatrist - Radiology 0103000695 (Virginia)Secondary
213ER0200XPodiatrist - Radiology P0474 (District Of Columbia)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Edna C Holmes allows following entities to bill medicare on her behalf.
Provider NamePodiatry Home Care Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1750730628
PECOS PAC ID: 7911299011
Enrollment ID: O20160711001705

News Archive

FDA joins Tox21 collaboration for improved chemical screening

The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.

U of A develops new technology that enables personalized medicine

You wouldn't know it from appearances, but a metal cube the size of a toaster, created at the University of Alberta, is capable of performing the same genetic tests as most fully equipped modern laboratories-and in a fraction of the time.

UC Denver researcher awarded NIH grant to study PAH

A disease that has no cure in young children and adults is getting closer attention, thanks to a University of Colorado Denver Bioengineering assistant professor and a five year National Heart Lung and Blood Institute/National Institutes of Health grant. Kendall Hunter, PhD, will perform research to improve the diagnosis and prognosis of pulmonary arterial hypertension in children and adults with approximately $700,000 over a five-year period.

Brain mitochondria are dysfunctional in early-stage Alzheimer's

Mitochondria - subunits inside cells that produce energy - have long been thought to play a role in Alzheimer's disease. Now Mayo Clinic researchers using genetic mouse models have discovered that mitochondria in the brain are dysfunctional early in the disease.

Columbia Laboratories shareholders approve Watson's aquisition terms

Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia's CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

Read more Medical News

› Verified 9 days ago

Provider NameNew Era Healthcare Inc.
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1326695339
PECOS PAC ID: 2365852621
Enrollment ID: O20201028001065

News Archive

FDA joins Tox21 collaboration for improved chemical screening

The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.

U of A develops new technology that enables personalized medicine

You wouldn't know it from appearances, but a metal cube the size of a toaster, created at the University of Alberta, is capable of performing the same genetic tests as most fully equipped modern laboratories-and in a fraction of the time.

UC Denver researcher awarded NIH grant to study PAH

A disease that has no cure in young children and adults is getting closer attention, thanks to a University of Colorado Denver Bioengineering assistant professor and a five year National Heart Lung and Blood Institute/National Institutes of Health grant. Kendall Hunter, PhD, will perform research to improve the diagnosis and prognosis of pulmonary arterial hypertension in children and adults with approximately $700,000 over a five-year period.

Brain mitochondria are dysfunctional in early-stage Alzheimer's

Mitochondria - subunits inside cells that produce energy - have long been thought to play a role in Alzheimer's disease. Now Mayo Clinic researchers using genetic mouse models have discovered that mitochondria in the brain are dysfunctional early in the disease.

Columbia Laboratories shareholders approve Watson's aquisition terms

Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia's CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

Read more Medical News

› Verified 9 days ago

Provider NameEastern Podiatry Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1598421422
PECOS PAC ID: 1951448711
Enrollment ID: O20211220001211

News Archive

FDA joins Tox21 collaboration for improved chemical screening

The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.

U of A develops new technology that enables personalized medicine

You wouldn't know it from appearances, but a metal cube the size of a toaster, created at the University of Alberta, is capable of performing the same genetic tests as most fully equipped modern laboratories-and in a fraction of the time.

UC Denver researcher awarded NIH grant to study PAH

A disease that has no cure in young children and adults is getting closer attention, thanks to a University of Colorado Denver Bioengineering assistant professor and a five year National Heart Lung and Blood Institute/National Institutes of Health grant. Kendall Hunter, PhD, will perform research to improve the diagnosis and prognosis of pulmonary arterial hypertension in children and adults with approximately $700,000 over a five-year period.

Brain mitochondria are dysfunctional in early-stage Alzheimer's

Mitochondria - subunits inside cells that produce energy - have long been thought to play a role in Alzheimer's disease. Now Mayo Clinic researchers using genetic mouse models have discovered that mitochondria in the brain are dysfunctional early in the disease.

Columbia Laboratories shareholders approve Watson's aquisition terms

Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia's CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Edna C Holmes is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Edna C Holmes, DPM
1700 Rosedale Ct,
Woodbridge, VA 22191-3016

Ph: () -
Dr Edna C Holmes, DPM
1700 Rosedale Ct,
Woodbridge, VA 22191-3016

Ph: (703) 494-3070

News Archive

FDA joins Tox21 collaboration for improved chemical screening

The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.

U of A develops new technology that enables personalized medicine

You wouldn't know it from appearances, but a metal cube the size of a toaster, created at the University of Alberta, is capable of performing the same genetic tests as most fully equipped modern laboratories-and in a fraction of the time.

UC Denver researcher awarded NIH grant to study PAH

A disease that has no cure in young children and adults is getting closer attention, thanks to a University of Colorado Denver Bioengineering assistant professor and a five year National Heart Lung and Blood Institute/National Institutes of Health grant. Kendall Hunter, PhD, will perform research to improve the diagnosis and prognosis of pulmonary arterial hypertension in children and adults with approximately $700,000 over a five-year period.

Brain mitochondria are dysfunctional in early-stage Alzheimer's

Mitochondria - subunits inside cells that produce energy - have long been thought to play a role in Alzheimer's disease. Now Mayo Clinic researchers using genetic mouse models have discovered that mitochondria in the brain are dysfunctional early in the disease.

Columbia Laboratories shareholders approve Watson's aquisition terms

Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that shareholders of Columbia Laboratories, Inc. (Nasdaq: CBRX) have approved the terms and conditions of the previously announced acquisition by Watson of the U.S. rights to Columbia's CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

Read more News

› Verified 9 days ago


Podiatrist in Woodbridge, VA

Dr. Owmy Bouloute, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 5049 Anchorstone Dr, Woodbridge, VA 22192
Phone: 678-517-4214    
Bouloute Healthcare Services, Llc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 5049 Anchorstone Dr, Woodbridge, VA 22192
Phone: 678-517-4214    
Dr. Peter Neil Brieloff, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 14010 Smoketown Rd Ste 103, Woodbridge, VA 22192
Phone: 703-583-5959    
Foot And Ankle Specialists Of The Mid-atlantic Llc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 1721 Financial Loop, Woodbridge, VA 22192
Phone: 703-491-9500    Fax: 703-491-9994
Progressive Feet Llc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 2296 Opitz Blvd Ste 510, Woodbridge, VA 22191
Phone: 571-285-4208    Fax: 571-285-4240
Potomac Podiatry Pllc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 14010 Smoketown Rd Ste 103, Woodbridge, VA 22192
Phone: 703-583-5959    Fax: 703-583-5995

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.